ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
1,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1,3,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
3,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
3,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
6,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
7,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
7,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
8,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
9,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
11,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
12,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
12,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
13,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
13,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
14,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
14,2,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
15,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
16,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
17,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
17,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
18,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
18,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
18,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
20,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
20,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
21,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
21,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
22,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
22,2,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
22,3,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
23,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
24,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
24,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
25,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
26,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
27,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
27,2,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
27,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
28,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
28,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
28,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
28,4,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
29,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
30,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
31,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
32,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
33,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
34,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
35,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
36,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
37,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
37,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
37,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
38,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
39,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
39,2,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
40,1,Cerebral artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
40,2,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
41,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
42,1,Headache,Headaches NEC,Headaches,Nerv,Y
43,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
44,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
44,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
45,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
46,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,Y
47,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
48,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
48,2,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
49,1,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
50,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,Y
51,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
52,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
53,1,Marrow hyperplasia,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
53,2,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
54,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
54,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
55,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
55,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
56,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
56,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
57,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
58,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
58,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
58,3,Headache,Headaches NEC,Headaches,Nerv,N
59,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
60,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
60,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
61,1,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
61,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
62,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
62,2,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,Y
63,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
64,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
65,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
66,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
67,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
68,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
70,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
71,1,Anaemia vitamin B12 deficiency,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
71,2,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
72,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
73,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
74,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
75,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
76,1,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
77,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
78,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
79,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
80,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
81,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
82,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
83,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
83,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
83,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
83,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
85,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
85,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
86,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
87,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
88,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
88,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
89,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
89,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
89,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
90,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
91,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
92,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
93,1,Congenital brain damage,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
94,1,Myxoedema,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
95,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
96,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
97,1,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
98,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
98,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
99,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
100,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
100,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
100,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
101,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
101,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
101,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
101,4,Logorrhoea,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
101,5,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
101,6,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
102,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
103,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
104,1,Meningitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
105,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
105,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
106,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
106,2,Meningitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,Y
106,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
106,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
107,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
108,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
108,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
108,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
109,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
110,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
110,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
110,3,Sickle cell anaemia with crisis,Sickle cell trait and disorders,Haemoglobinopathies,Blood,N
111,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
112,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
113,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
113,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
113,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
113,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
114,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
115,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
116,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
117,2,Phaeochromocytoma,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
117,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
118,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
118,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
119,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
120,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
120,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
120,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
120,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
120,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
121,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
122,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
122,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
122,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
122,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
122,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
123,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
124,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
125,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
125,2,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
126,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
126,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
126,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
126,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
127,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
127,2,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
127,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
127,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
128,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
129,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
129,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
130,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
131,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
132,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
133,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
133,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
133,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
133,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
133,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
133,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
133,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
134,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
135,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
135,2,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
135,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
136,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
136,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
136,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
136,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
136,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
136,6,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
137,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
137,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
138,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
139,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
140,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
140,2,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
141,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
141,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
141,3,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
142,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
142,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
142,3,Optic nerve sheath haemorrhage,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
143,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
144,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
145,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
145,2,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
145,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
145,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
146,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
146,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
147,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
148,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
148,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
149,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
150,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
150,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
150,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
151,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
151,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
152,1,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
153,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
153,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
153,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
153,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
153,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
153,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
153,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
154,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
154,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
155,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
155,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
155,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
155,4,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
155,5,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
155,6,Monocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
155,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
155,8,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
155,9,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
157,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
157,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
157,3,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
157,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
157,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
157,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
157,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
157,8,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
157,9,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
157,10,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
157,11,Mediastinitis,Infections NEC,Infections - pathogen unspecified,Infec,N
157,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
157,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
157,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
158,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
158,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
158,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
158,5,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
159,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
159,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
159,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
159,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
159,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
159,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
159,8,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
159,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
159,10,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
159,11,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
159,12,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
160,1,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
161,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
161,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
162,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
162,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
162,3,Headache,Headaches NEC,Headaches,Nerv,N
162,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
162,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
162,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
162,7,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
162,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
163,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
163,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
163,3,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,Y
163,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
163,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
163,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
164,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
164,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
165,1,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
165,2,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
166,1,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
166,2,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
167,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
167,2,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
168,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
168,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
169,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
169,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
169,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
169,4,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
169,5,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
170,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
170,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
170,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
170,4,Twin pregnancy,Multiple pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
171,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
172,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
172,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
172,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
173,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
174,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
174,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
175,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
175,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
175,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
175,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
175,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
176,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
176,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
176,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
176,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
176,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
176,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
177,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
177,3,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
177,4,Ulcerated haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
178,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
178,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
178,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
178,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
179,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
179,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
179,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
180,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
181,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
181,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
181,4,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
181,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
181,6,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
182,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
182,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
182,3,Hypoproteinaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
182,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
182,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
182,6,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
183,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
183,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
183,3,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
183,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
183,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
183,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
183,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
183,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
183,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
183,10,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
183,11,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
183,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
183,13,Post herpetic neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
183,14,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
183,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
184,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
184,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
185,1,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,Y
186,1,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,Y
187,1,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,Y
188,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
188,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
188,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
188,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
188,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
189,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
190,1,Hypertensive crisis,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
191,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
191,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
192,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
192,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
192,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
192,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
192,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
192,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
192,7,Sebaceous gland disorder,Sebaceous gland disorders,Skin appendage conditions,Skin,N
193,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
194,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
195,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
195,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
195,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
195,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
195,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
195,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
195,7,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
195,8,Glomerulonephritis rapidly progressive,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
195,9,Glomerulosclerosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
195,10,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
195,11,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
195,12,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
195,13,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
195,14,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
195,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
195,16,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
195,17,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
195,18,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
195,19,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
195,20,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
196,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
196,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
196,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
196,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
196,5,Monoclonal immunoglobulin present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
196,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
197,1,Lactation insufficiency,Lactation disorders,Breast disorders,Repro,N
197,2,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
198,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
198,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
198,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
199,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
200,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
201,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
201,2,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
202,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
202,2,Herpes zoster oticus,Herpes viral infections,Viral infectious disorders,Infec,N
202,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
202,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
203,1,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
203,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
203,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
204,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
204,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
205,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
205,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
205,3,Cytomegalovirus enteritis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
205,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
205,5,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
205,6,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
205,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
205,8,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
205,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
206,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
206,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
206,3,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
206,4,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
206,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
206,6,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
206,7,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
206,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
206,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
206,10,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
206,12,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
206,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
206,14,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
206,15,Mucosal dryness,Mucosal findings abnormal,General system disorders NEC,Genrl,N
206,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,17,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
206,18,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
206,19,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
206,20,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
207,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
208,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
208,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
208,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
209,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
209,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
209,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
209,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
209,5,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
209,6,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
209,7,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
209,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
209,9,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
209,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
210,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
210,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
210,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
210,4,Renal and pancreas transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
211,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
211,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
212,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
212,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
213,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
214,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
214,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
214,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
214,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
214,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
214,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
215,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
215,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
216,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
216,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
216,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
216,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
217,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
217,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
217,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
217,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
217,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
218,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
219,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
219,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
219,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
219,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
219,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
219,6,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
219,7,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
219,8,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
219,9,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
219,10,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
219,11,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
219,12,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
219,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
219,14,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
219,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
220,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
220,2,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
221,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
221,2,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
222,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
222,2,Cytomegalovirus enteritis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
222,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
222,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
222,5,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
222,6,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
222,7,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
222,8,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
223,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
224,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
224,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
224,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
224,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
224,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
224,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
225,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
225,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
225,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
226,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
226,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
226,3,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
227,1,Bloody discharge,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
227,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
227,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
227,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
227,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
227,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
227,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
227,8,International normalised ratio fluctuation,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
227,9,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
227,10,Lyme disease,Borrelial infections,Bacterial infectious disorders,Infec,N
227,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
227,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,13,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
227,14,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
227,15,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
227,16,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
227,17,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
227,18,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
227,19,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
228,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
228,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
228,3,Eosinophilic granulomatosis with polyangiitis,Vasculitides,Immune disorders NEC,Immun,N
228,4,Eosinophilic myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
228,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
228,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
229,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
229,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
229,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
229,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
229,5,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
230,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
230,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
230,3,Eosinophilic granulomatosis with polyangiitis,Vasculitides,Immune disorders NEC,Immun,N
230,4,Eosinophilic myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
230,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
231,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
231,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
231,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
231,4,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
231,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
231,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
231,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
231,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
232,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
232,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
233,1,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
233,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
233,3,Coarctation of the aorta,Great vessel disorders congenital,Cardiac and vascular disorders congenital,Cong,N
233,4,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
233,5,Congenital diaphragmatic hernia,Diaphragmatic disorders congenital,Respiratory disorders congenital,Cong,N
233,6,Congenital nail disorder,Hair and nail disorders congenital,Skin and subcutaneous tissue disorders congenital,Cong,N
233,7,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
233,8,Dysmorphism,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
233,9,Fryns syndrome,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
233,10,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
233,11,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
233,12,Microtia,External ear disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
233,13,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
233,14,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,Y
233,15,Tracheo-oesophageal fistula,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
234,1,BK polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
235,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
235,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
237,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
237,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
238,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
239,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
239,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
239,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
239,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
239,5,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
239,6,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
239,7,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,Y
240,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
240,2,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
240,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
240,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
240,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
240,6,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
240,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
240,8,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
240,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
240,10,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
240,11,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
240,12,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
241,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
241,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
241,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
241,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
241,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
241,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
241,7,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
241,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
241,9,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
241,10,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
241,11,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
242,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
242,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
242,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
242,4,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
243,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
243,2,Laryngeal stenosis,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
243,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
243,4,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
243,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
244,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
244,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
244,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
244,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
244,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
244,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
244,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
244,8,Natural killer-cell lymphoblastic lymphoma,Precursor T-lymphoblastic lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
244,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
244,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
245,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
245,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
246,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
247,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
247,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
247,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
248,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
248,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
248,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
249,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
249,2,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
250,1,B-cell lymphoma stage IV,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
250,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
250,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
250,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
251,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
251,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
251,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
251,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
251,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
251,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
252,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
252,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
253,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
254,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
254,2,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
254,3,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
254,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
254,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
254,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
254,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
254,8,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
254,9,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
254,10,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
254,11,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
254,12,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
254,13,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
254,14,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
254,15,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
254,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
255,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
255,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
255,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
255,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
256,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
256,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
256,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
256,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
256,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
257,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
257,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
257,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
257,4,Babesiosis,Babesia infections,Protozoal infectious disorders,Infec,N
257,5,Blood chloride decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
257,6,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
257,7,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
257,8,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
257,9,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
257,10,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
257,11,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
257,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
257,13,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
257,14,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
257,15,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
257,16,Haptoglobin decreased,Haem metabolism analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
257,17,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
257,18,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
257,19,Mucosal dryness,Mucosal findings abnormal,General system disorders NEC,Genrl,N
257,20,Myalgia,Muscle pains,Muscle disorders,Musc,N
257,21,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
257,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
257,23,Pyuria,Infections NEC,Infections - pathogen unspecified,Infec,N
257,24,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
257,25,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
257,26,Skin turgor decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
258,1,Acute biphenotypic leukaemia,Leukaemias acute NEC,Leukaemias,Neopl,N
258,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
258,3,Blast cells present,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
258,4,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
258,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
258,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
258,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
258,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
258,9,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
258,10,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
258,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
259,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
259,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
259,3,Headache,Headaches NEC,Headaches,Nerv,N
260,1,Reversible cerebral vasoconstriction syndrome,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
260,2,Thunderclap headache,Headaches NEC,Headaches,Nerv,N
261,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
262,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
262,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
262,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
263,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
263,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
263,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
263,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
263,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
263,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
263,7,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
263,8,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
263,9,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
263,10,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
263,11,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
263,12,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
263,13,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
263,14,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
263,15,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
263,16,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
263,17,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
263,18,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
263,19,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
263,20,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
263,21,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
264,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
264,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
265,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
265,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
266,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
266,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
267,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
267,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
267,3,Indifference,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
267,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
268,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
268,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
269,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
270,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
270,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
270,3,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
270,4,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
270,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
270,6,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
270,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
271,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
271,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
272,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
272,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
272,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
273,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
273,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
273,3,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
273,4,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
273,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
273,6,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
273,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
274,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
274,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
274,3,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
274,4,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
274,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
274,6,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
274,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
275,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
275,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
275,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
275,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
276,1,Encephalitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
277,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
277,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
277,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
278,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
279,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
279,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
279,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
280,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
280,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
280,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
280,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
281,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
282,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
282,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
282,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
282,4,Radicular pain,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
282,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
282,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
283,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
283,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
284,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
284,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
284,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
284,4,Waldenstrom's macroglobulinaemia,Waldenstrom's macroglobulinaemias,Lymphomas non-Hodgkin's B-cell,Neopl,Y
285,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
285,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
285,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
285,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
285,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
285,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
286,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
286,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
287,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
287,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
288,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
289,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
289,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
289,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
289,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
289,5,Purpura fulminans,Purpura and related conditions,Skin vascular abnormalities,Skin,N
289,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
290,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
291,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
292,1,Systolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
293,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
293,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
294,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
294,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
295,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
296,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
297,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
297,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
297,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
297,4,Language disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
297,5,Respiratory tract congestion,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
297,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
297,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
298,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
298,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
298,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
298,4,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
298,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
298,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
299,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
299,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
299,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
300,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
300,2,Headache,Headaches NEC,Headaches,Nerv,N
300,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
300,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
301,1,Eosinophilic fasciitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
302,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
302,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
302,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
302,4,Headache,Headaches NEC,Headaches,Nerv,N
302,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
303,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
303,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
303,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
304,1,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
305,1,Eosinophilic fasciitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
306,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
306,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
306,3,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
307,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
307,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
307,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
307,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
307,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
307,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
307,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
307,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
307,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
307,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
308,1,Ejection fraction abnormal,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
308,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
308,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
309,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
309,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
309,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
310,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
310,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
310,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
311,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
312,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
312,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
312,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
312,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
312,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
313,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
314,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
315,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
315,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
316,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
316,2,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
317,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
317,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
318,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
318,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
318,3,Enzyme abnormality,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
318,4,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
318,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
318,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
318,7,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
318,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
318,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
318,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
318,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
318,12,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
318,13,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
318,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
318,15,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
318,16,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
318,17,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
318,18,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
319,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
320,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
321,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
322,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
323,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
324,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
325,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
326,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
327,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
328,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
329,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
330,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
331,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
332,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
333,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
334,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
335,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
336,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
337,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
338,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
339,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
340,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
341,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
342,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
343,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
344,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
345,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
346,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
347,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
348,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
349,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
350,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
351,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
352,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
353,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
354,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
355,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
356,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
357,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
358,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
359,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
360,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
361,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
362,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
363,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
364,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
365,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
366,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
366,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
366,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
366,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
366,5,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
366,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
367,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
368,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
369,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
370,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
371,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
372,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
373,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
374,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
375,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
376,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
377,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
378,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
379,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
380,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
381,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
382,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
383,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
384,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
385,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
386,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
387,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
388,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
389,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
390,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
391,1,Extramedullary haemopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
391,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
392,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
392,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
393,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
393,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
393,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
394,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
395,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
396,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
396,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
396,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
396,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
396,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
396,6,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
396,7,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
396,8,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
396,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
397,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
397,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
397,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
397,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
397,5,Transfusion-related circulatory overload,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
397,6,Traumatic haematoma,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
398,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
398,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
399,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
399,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
399,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
399,4,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
399,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
399,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
400,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
400,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
400,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
400,4,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
401,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
401,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
401,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
401,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
401,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
401,6,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
401,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
401,8,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
401,9,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
401,10,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
401,11,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
401,12,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
401,13,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
401,14,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
401,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
401,16,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
401,17,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
401,18,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
401,19,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
401,20,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
401,21,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
401,22,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
401,23,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
401,24,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
401,25,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
401,26,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
401,27,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
401,28,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
402,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
403,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
403,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
403,3,Congestive hepatopathy,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
403,4,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
403,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
403,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
404,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
404,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
404,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
405,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
406,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
406,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
406,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
406,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
406,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
406,6,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
406,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
406,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
406,9,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
406,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
407,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
407,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
407,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
408,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
408,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
408,3,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
408,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
408,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
408,6,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
408,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
408,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
409,1,Eosinophilic granulomatosis with polyangiitis,Vasculitides,Immune disorders NEC,Immun,N
409,2,Eosinophilic myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
409,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
410,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
410,2,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
410,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
410,4,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
410,5,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
410,6,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
410,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
410,8,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
410,9,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
410,10,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
410,11,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
410,12,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
410,13,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
410,14,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
410,15,Intentional device misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
410,16,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
410,17,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
410,18,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
410,19,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
410,20,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
410,21,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
411,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
412,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
412,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
412,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
412,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
412,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
412,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
412,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
412,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
412,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
412,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
412,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
412,12,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
412,13,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
413,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
413,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
414,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
414,2,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
414,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
414,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
414,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
414,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
414,7,Lip exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
414,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
414,9,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
414,10,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
414,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
414,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
414,13,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
414,14,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
414,15,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
414,16,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
414,17,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
415,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
416,1,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
417,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
418,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
418,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
418,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
418,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
418,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
418,6,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
419,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
419,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
420,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
420,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
420,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
421,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
421,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
421,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
421,4,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
421,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
421,6,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
421,7,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
421,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
421,9,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
421,10,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
422,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
422,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
423,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
423,2,Aversion,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
423,3,Aversion,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
423,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
423,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
423,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
423,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
423,8,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
423,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
423,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
423,11,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
423,12,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
423,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
424,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
424,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
424,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
425,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
426,1,Headache,Headaches NEC,Headaches,Nerv,N
426,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
427,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
428,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
428,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
429,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
429,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
429,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
429,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
430,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
431,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
431,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
431,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
431,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
431,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
431,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
431,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
431,8,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
432,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
432,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
433,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
434,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
435,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
435,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
435,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
435,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
435,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
436,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
436,2,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,Y
436,3,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
436,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
436,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
436,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
436,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
436,8,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
436,9,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
436,10,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
436,11,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
436,12,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
436,13,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
436,14,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
436,15,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
436,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
437,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
437,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
437,3,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
438,1,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
438,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
438,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
438,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
438,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
438,6,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
438,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
438,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
439,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
439,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
439,3,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
440,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
440,2,T-cell lymphoma refractory,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
441,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
441,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
441,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
441,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
442,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
442,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
442,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
442,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
442,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
442,6,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
443,1,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
444,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
444,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
444,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
445,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
446,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
447,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
448,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
448,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
449,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
449,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
449,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
449,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
449,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
449,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
449,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
449,8,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
449,9,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
449,10,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
449,11,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
449,12,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
449,13,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
449,14,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
449,15,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
449,16,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
449,17,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
449,18,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
449,19,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
449,20,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
449,21,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
449,22,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
449,23,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
450,1,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
451,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
452,1,Acne,Acnes,Skin appendage conditions,Skin,N
452,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
452,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
452,4,Myopathy,Myopathies,Muscle disorders,Musc,N
452,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
452,6,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
453,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
453,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
453,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
453,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
453,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
453,6,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
453,7,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
453,8,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
453,9,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
453,10,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
453,11,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
453,12,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
453,13,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
453,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
454,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
455,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
456,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
457,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
458,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
458,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
458,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
458,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
458,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
458,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
459,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
459,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
460,1,Acne,Acnes,Skin appendage conditions,Skin,N
460,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
460,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
460,4,Myopathy,Myopathies,Muscle disorders,Musc,N
460,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
460,6,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
460,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
461,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
462,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
462,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
462,3,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
463,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
464,1,Bladder irritation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
464,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
464,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
464,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
464,5,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
464,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
465,1,Ocular surface squamous neoplasia,Ocular neoplasms malignancy unspecified,Ocular neoplasms,Neopl,N
466,1,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
466,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
466,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
466,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
466,5,Stoma site reaction,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
467,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
467,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
467,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
467,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
468,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
468,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
468,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
469,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
470,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
471,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
471,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
472,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
472,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
473,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
474,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
475,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
476,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
477,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
477,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
478,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
478,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
478,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
479,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
479,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
480,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
481,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
481,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
481,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
481,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
482,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
482,2,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
483,1,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
484,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
485,1,Anaplastic large cell lymphoma T- and null-cell types,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
486,1,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
487,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
487,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
488,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
488,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
489,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
489,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
490,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
490,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
490,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
490,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
490,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
490,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
490,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
490,8,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
490,9,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
490,10,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
490,11,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
490,12,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
490,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
490,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
490,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
490,16,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
490,17,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
490,18,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
490,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
491,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
491,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
492,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
493,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
494,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
494,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
494,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
495,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
496,1,Anorectal malformation,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
496,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
496,3,Blood bicarbonate increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
496,4,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
496,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
496,6,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
496,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
496,8,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,9,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,10,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
496,12,Mean cell haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,13,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,14,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
496,16,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
496,17,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,18,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,19,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
496,20,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,21,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
496,22,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,23,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
497,1,Genital infection,Infections NEC,Infections - pathogen unspecified,Infec,N
497,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
497,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
497,4,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
497,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
497,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
497,7,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
497,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
497,9,Vulval abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
498,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
499,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
499,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
500,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
501,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
502,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
503,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
503,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
503,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
504,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
504,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
505,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
505,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
505,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
505,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
505,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
505,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
505,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
506,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
507,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
508,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
508,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
509,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
510,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
510,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
510,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
511,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
512,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
513,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
514,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
515,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
516,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
517,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
517,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
517,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
518,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
519,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
520,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
521,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
522,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
523,1,Cerebral vasoconstriction,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
523,2,Cryptococcal meningoencephalitis,Cryptococcal infections,Fungal infectious disorders,Infec,N
523,3,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
523,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
523,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
523,6,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
523,7,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
523,8,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
524,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
525,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
526,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
527,1,B-cell lymphoma recurrent,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
527,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
527,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
528,1,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
529,1,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
530,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
531,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
532,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
533,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
533,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
533,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
533,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
533,5,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
534,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
534,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
535,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
535,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
536,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
536,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
537,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
537,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
538,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
538,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
539,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
540,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
541,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
541,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
542,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
543,1,Heart rate,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
544,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
544,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
545,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
545,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
546,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
546,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
546,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
546,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
546,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
546,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
546,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
546,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
546,9,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
546,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
547,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
547,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
547,3,Blood antidiuretic hormone,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
547,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
547,5,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
547,6,Headache,Headaches NEC,Headaches,Nerv,N
547,7,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
547,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
547,9,Hypertensive emergency,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
547,10,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
547,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
548,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
548,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
548,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
548,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
548,5,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
549,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
550,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
550,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
551,1,Pneumonia cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,N
551,2,Pneumonia klebsiella,Klebsiella infections,Bacterial infectious disorders,Infec,N
552,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
552,2,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
553,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
554,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
554,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
555,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
556,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
556,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
557,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
557,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
557,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
558,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
558,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
558,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
559,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
559,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
559,3,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
559,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
559,5,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
560,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
560,2,Anhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
560,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
560,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
560,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
560,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
560,7,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
560,8,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
561,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
562,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
562,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
562,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
562,4,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
563,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
564,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
564,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
564,3,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
564,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
565,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
565,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
565,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
566,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
566,2,Headache,Headaches NEC,Headaches,Nerv,N
566,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
567,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
568,1,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
568,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
568,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
568,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
568,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
568,6,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
568,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
568,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
568,9,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
569,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
569,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
569,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
570,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
571,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
571,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
572,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
572,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
572,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
572,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
572,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
572,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
